News

Aenova Group, a leading international contract developer and manufacturer for the pharmaceutical and healthcare industries, presents its new sterile strategy. In the future, the focus in sterile produ ...

Effective March 01, 2023, Dr. Hanno Scheffczik has been appointed as the new Managing Director of Temmler Pharma GmbH, a member of the Aenova Group. The experienced general manager leads the site in M ...

Employees of the pharmaceutical contract manufacturer Aenova organized an internal donation for the Starnberger Tafel in December 2022. The official, symbolic handover of the check took place on Febru ...

Producing billions of capsules each year, Aenova is a partner of choice for novel product solutions as well as commercial high-volume manufacturing of hard capsule products. At the Regensburg site, o ...

Aenova employees collected donations in kind and money for social institutions in Starnberg at the beginning of December 2022. These donations will be used to support two organizations that help disad ...

Training is of great importance at Aenova. With over 80 trainees within the Aenova Group, vocational training for the next generation is an integral part at all Aenova locations.At the career informat ...

Aenova has contributed an exclusive expert article to the current issue of the renowed magazine "European Pharmaceutical Manufacturer", 11/12 2022, with the title: Innovations in oral solid dosage fo ...

It's been a long time since there was so much going on at our manufacturing sites in Kirchberg and Sisseln, Switzerland: both sites were buzzing like a beehive, so many interested young students had r ...

The best trainees in Lower Saxony were honored last week at the GOP Varieté Theater in Hanover: 110 young professionals completed their vocational training at IHK member companies this year with the g ...

Dry powder inhalation using a DPI device (dry powder inhaler) is becoming more and more important for patient care in view of the worldwide increase in lung and respiratory diseases. The need for ther ...

Aenova CEO Jan Kengelbach gives a statement on the current macroeconomic situation in the current issue of CHEManager (10/2022). With the title "Fewer drugs at higher prices? The supply of pharmaceut ...

The Aenova Group is a leading global contract manufacturer and development service provider for the pharmaceutical and healthcare industry. As a one-stop-shop, Aenova develops, produces and packages a ...

The 14th Training Day in Traunstein gives students a comprehensive overview of the professions and training courses or secondary schools in the Chiemgau / Southeast Bavaria region. In addition, numero ...

"Nacht schafft Wissen" (Night Creates Knowledge) is a format that is now well established in Regensburg to bring "Innovations made in Regensburg" closer to the people. The event focuses on research, s ...

The market for HPAPI (High Potent Active Pharmaceutical Ingredients) will continue to grow in the coming years and decades. HPAPIs are used, among other indications, for the treatment of oncological d ...

For an API (active pharmaceutical ingredient), i.e. the active pharmaceutical ingredient of a drug, to have an optimal effect on the patient, the formulation is an essential component. It therefore ma ...

The development of new drug products for a wide range of therapeutic areas is a rapidly growing market. Therefore, a smart innovation strategy is essential for contract developers and manufacturers. A ...

Neil Jones has been the new Chief Commercial Officer (CCO) of Aenova Group since July 18, 2022. As a member of the Executive Leadership Team (ELT), he will play a key role in shaping the future and co ...

The Aenova Group publishes its 2021 Annual Report today. The key figures 2021 of Aenova at a glance:€107 million adjusted EBITDA*€125 million in additional new projects89 % on-time deliveries (annua ...

As a global leader in contract development and manufacturing, Aenova focuses on innovation, including digital transformation of supply chain management. As a successor system to SAP APO, the planning ...

The Aenova site in Sisseln, Switzerland, stands for many years of tradition and special know-how, including in the production and packaging of moisture-sensitive solid dosage forms. A comprehensive su ...

Aenova, global leading contract development and manufacturing organisation for the pharmaceutical and healthcare industries, signed the "Diversity Charter", a voluntary commitment to diversity, at the ...

In the latest edition of Global Business Reports' renowned US Life Sciences 2022 Report, Aenova outlines its technology and innovation strategy.In the interview, Aenova CEO Jan Kengelbach explains the ...

Finally, trade fairs can take place in presence again! Our HR team and trainees at the site in Tittmoning in southern Bavaria were also happy about this.At the training fair "Ausbildungsroas" in near ...

Aenova, globally leading contract development and manufacturer for the pharmaceutical and healthcare industries, has achieved silver status in the latest EcoVadis sustainability rating. This documents ...

The latest Actif's Magazine features an interview with Michael Ammann, Head of Business Unit Softgel Capsules at Aenova, about the development of Vegan Softgel Capsules at Aenova. The new generation ...

Aenova has laid the foundation for the new building for highly potent active ingredients at its Regensburg site. Highly potent drugs, especially against cancer, are produced in the new manufacturing f ...

Tim Bauer has been the new Senior Vice President (SVP) Corporate Human Resources at Aenova's Starnberg site since September 2021. He is responsible for all human resources tasks for around 4,200 emplo ...

Aenova, global leading development service provider and contract manufacturer for the pharmaceutical and healthcare industries, is expanding environmental certifications. At the end of 2021, the Aenov ...

Within just two weeks, the Aenova Group has reached the set joint donation target of €100,000 to support Ukraine. "With this campaign, we were able to make a significant contribution very quickly to s ...

Welcome to Aenova: we would like to introduce our new Managing Director at the Gronau site, Dr. Frank Küpker. Mr. Küpker looks back on a long career with well-known companies in the pharmaceutical in ...

Every day we can see in the news what unimaginable suffering the war brings to the people in Ukraine. As the Aenova Group, we want to and can help. In accordance with our corporate value "Together we ...

Aenova, global leading development services provider and contract manufacturer for the pharmaceutical and healthcare industries, presents its investment strategy for 2022 to 2025. The focus is on majo ...

In the study "Germany's Best Employers", Aenova receives the rating "Company with very high attractiveness" in the category "Industry". More than 800,000 citizens in Germany were surveyed about a tota ...

The Aenova Group is now one of the signatories of the UN Global Compact, a worldwide initiative for sustainable and responsible corporate governance. By participating in the UN Global Compact, Aenova ...

The Bad Aiblinger Tafel's "One More" campaign is a pre-Christmas donation initiative that has been established for years and is supported by many local grocery stores. The additional one item more tha ...

Cannabinoids can provide great benefits for the treatment of cancer and central nervous system diseases. Softgel capsules are the preferred delivery form for cannabinoid products for many reasons. Aen ...

The Premio Industria Felix was awarded to the 160 best Italian companies by industry on Nov. 25, 2021 in Rome. The Aenova site in Latina, Haupt Pharma Latina S.r.l., is among the award winners. The aw ...

The Chamber of Commerce Switzerland-Romania has recently launched the “Who’s who” series of profile interviews about the CEOs managing the member companies.In the current issue, our Managing Director ...

Aenova has significantly expanded its sterile fill and finish capacity at its Italian site in Latina. The new state-of-the-art aseptic production area features a completely new high-speed flexible lin ...

At the Jefferies Healthcare Conference from 16 to 19 November 2021 in London Aenova was participating with a presentation. Aenova CEO Jan Kengelbach gives in his presentation an overview of the broad ...

The investment project to expand tablet manufacturing capacity is nearing completion; routine operations will start in the second quarter of 2022. With the commissioning of the third high-volume line, ...

The new probiotic formulations are based on a dedicated shell combined with suitable fill mass enhancers. The new capsules are easy to swallow. The capsule content can be adapted to special needs and ...

Aenova has significantly expanded its sterile fill and finish capacity at its Italian site in Latina. The new state-of-the-art aseptic production area features a completely new high-speed flexible lin ...

The new softgel capsules are based on the vegan Aenova VegaGels® and are filled with omega-3 DHA fatty acids from microalgae.The chewable vegan softgel capsule is easy to take.Available in Tutti-Frutt ...

Welcome to Aenova: We would like to introduce our Senior Vice President Human Resources Tim Bauer. Mr. Bauer previously worked for many years in HR for manufacturing companies, where he held various r ...

Aenova at the site in Cornu, Romania, now received a Certificate on Greenhouse Gas Emission Reductions for 2020.This certificate was issued based on the calculations made by the environmental engineer ...

The Corona pandemic posed particular challenges to the world of work and society over the past 15 months. This also applied to the proven cooperation between Swiss Caps GmbH, Member of the Aenova Grou ...

Aenova produces and packages soft gelatin capsules and vegan soft capsules as a contract manufacturer for large, international pharmaceutical and nutritional supplement companies at its Cornu, Romania ...

Aenova publishes its 2020 Annual Report today. The report summarises the business and highlights for 2020 and gives insights into the company’s strategy. Learn more about Aenova's 2020 achievements an ...

Aenova developed a comprehensive process and solution approach for marketing authorization holders.Already within the first regulatory deadline, all risk assessments for customers could be prepared.Th ...

When it comes to serialization of pharmaceuticals and dietary supplements, crypto codes are a special requirement for the Russian market.Since July 1, 2020, every drug offered for sale on the Russian ...

Special topics in times of pandemic: vaccines take center stage BIO Digital is the world's largest virtual biotech partnering and education event, convening thousands of global biotech leaders and inn ...

In order to expand its fill and finish capacity for the production of Biologics and especially BSL1 and BSL2 vaccines against the SARS-CoV-2 virus, the Aenova Group is currently building a new sterile ...

For the children of the Zuckenriet kindergarten near Kirchberg (CH), an interesting project turned into a true fantasy journey into space.Traveling in COVID-19 times: that's as good as impossible; tra ...

Recent studies show that contract manufacturers for the pharmaceutical industry, so-called CDMOs (contract development and manufacturing organizations), have so far been little involved in the product ...

Aenova CEO and Partner Jan Kengelbach of BC Partners, was a guest on the Unquote podcast, where he spoke to Editor Greg Gille about how to drive growth at an operational level. Listen to Jan discuss h ...

Aenova starts up the new RABS filling line for ampoules from 1 ml to 5ml.This is supplemented by fully automatic optical inspection and a new packaging line.This will enable the Gronau site to produce ...

With the new aseptic filling line at Aenova in Latina we link to an article in the Italian press (teaser in English see below): Vaccini, infialamento e produzione: ecco le aziende che possono farlo in ...

As a Contract Development and Manufacturing Organization in the pharmaceutical sector, Aenova plays a central role in the production and development of innovative drugs. In an interview with CHEManage ...

Aenova expands production of highly potent oncology drugs (up to OEB 5) with new tablet press. The fully automatic, online and process integrated control significantly increases process efficiency and ...

Aenova Group Vice President Global Procurement sketches the supply chain challenges and risk management approaches in times of a pandemic. „Stress Test for The Supply Chain“ – from: CHEManager Interna ...

Dr. Mike Schaefers joins the Aenova Group as new Senior Vice President Sales & Marketing: "For us, it's about our patients and customers. Reliability and a continuous focus on quality are of high ...

Aenova presents the new generation of its vegan soft capsules. The new VegaGels® are produced on a vegetable basis using new technology. The composition of the new soft capsules conforms to US, EU and ...

At SWISSCAPS Romania, member of the Aenova Group, the new photovoltaic system was put into operation. With an output of around 360 MWp, the photovoltaic plant contributes to a climate-friendly power s ...

As we navigate through an unprecedented global crisis, we want to update you on what Aenova Group is doing to address the COVID-19 pandemic.

On the company site of Dragenopharm Apotheker Püschl GmbH, member of the Aenova Group, a new production building is under construction. The production capacity of the site can thus be increased to ove ...

CHEManager International presents a survey of the pharmaceutical industry, including CDMOs, on what they believe are the key lessons learned from working under pandemic conditions to date and how the ...

More sustainable production thanks to new photovoltaic systemActive environmental protection with renewable energies: the SwissCaps Romania plant of Aenova Group in Cornu, specialist mainly in the pro ...

David Hitchcock is the new Head of Global Operational Excellence at Aenova Group: "I look forward to working with the teams at our sites to drive performance and further develop the culture of contin ...

In pharmaceutical development and production, quality and safety are the central issues. This naturally also applies to buildings and their infrastructure. Haupt Pharma Wülfing GmbH, a member of the A ...

Dr. Volker Viktor is the new Vice President Commercial Excellence at Aenova Group: "In everything we do, we always focus on the value we can achieve for our customers!"

Dr. Matthias Groh is the new Head of Business Development & Strategy at Aenova Group: "With its broad technological offering and international presence, Aenova Group is particularly well position ...

Aenova Group now announces the company's new organizational structure: with the three new business units Solids, Semi Solids & Liquids and Softgel Capsules, the company's 15 manufacturing sites wi ...

Dr. Franz Clementschitsch is the new Managing Director at the Wolfratshausen site: "I look forward to working with my team to drive quality, delivery reliability, service excellence and continuous imp ...

Thomas Lemke is the new Managing Director at the Bad Aibling site: "Quality, delivery reliability, service excellence and continuous improvement are important parameters - that is what we strive for a ...

Fridrik Thorsteinsson is the new Managing Director at the Sisseln site: "We are proud to produce 100% CO2-neutral and to offer cost-efficient quality solutions to our Aenova customers as a highly rel ...

Haupt Pharma Amareg GmbH, a member of the Aenova Group, has been supporting the city of Regensburg with disinfectants since the beginning of the Corona crisis. Since March 2020, 12,000 liters have alr ...

Immunic Therapeutics has received approval from the German Federal Institute for Drugs and Medical Devices (BfArM) to initiate a Phase 2 clinical trial with its selective oral DHODH inhibitor IMU-838 ...

Dr Pedro Diaz Kraus is the new Vice President Corporate HSES at Aenova Group: „At Aenova we care for our customers and our employees in matters of Health and Safety as well as maintaining high Enviro ...

Dr. Jörg Gampfer is the new head of development services at Aenova Group: „We offer a high level of quality and efficiency throughout all the stages of product development and manufacturing – that´s t ...

Prestigious Life Science Leader's CMO Leadership Award recognizes leaders in pharmaceutical contract manufacturing.

Aenova Group, one of the world's largest Contract and Development Manufacturing Organizations (CDMO) for the pharmaceutical industry, announced today that it has successfully completed the refinancing ...